David Hamilton facilitates a conversation with Lisa LeCointe-Cephas, partner and co-chair of the Life Sciences sector at DLA Piper, Kirsten Axelsen, senior policy advisor at DLA Piper, and Celeste Saravia, vice president at Cornerstone Research, on the impacts of the Inflation Reduction Act on innovation, competition, and pricing in the life sciences industry.

Algorithmic Pricing 2.0: Analyzing the intersection of AI and antitrust law
39:38

State AGs Focus in on Competition
28:08

The Robinson-Patman Act: Pricing Considerations for Retailers
36:33